Published March 2012 | Version v1
Journal article

Progress on p73 variant and its possible application in tumor radiotherapy

  • 1. Key Laboratory of Heavy Ion Radiation Medicine of Gansu Prevince, Lanzhou (China)
  • 2. Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Sciences, Lanzhou (China)
  • 3. Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou (China)

Description

p73 was the first identified homologue of the tumor suppressor gene, p53. p73 has two groups of protein isoforms: TAp73 and DNp73. TAp73 can induce cell cycle arrest, resulting in the ability of apoptosis, however DNp73 has antagonistic property of a tumor promoting effect. In this paper, the dual roles of p73 gene and its research progress was reviewed. Finally, combined with heavy ion treatment of tumor, we explored some new ideas of p73-heavy ion joint therapy. (authors)

Additional details

Publishing Information

Journal Title
Nuclear Physics Review
Journal Volume
29
Journal Issue
1
Journal Page Range
p. 103-108
ISSN
1007-4627

INIS

Country of Publication
China
Country of Input or Organization
China
INIS RN
45059216
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
APOPTOSIS; CELL CYCLE; GENES; HEAVY IONS; NEOPLASMS; PROTEINS; RADIOTHERAPY
Descriptors DEC
CHARGED PARTICLES; DISEASES; IONS; MEDICINE; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; RADIOLOGY; THERAPY

Optional Information

Notes
3 figs., 1 tabs., 39 refs.